The diagnosis and management of many conditions in andrology have been greatly influenced by recent pharmacological, surgical and basic science advances. One of the greatest challenges in this discipline is to keep abreast of the many dynamic changes in this field. An internationally acclaimed faculty hass been assembled to provide this update, with presentations on topics such as Transgender Surgery, Genitourinary Tissue Regeneration, Male Sexual Dysfunction, Male Infertility, Reproductive Biology, and Stem Cell Biology. During the plenary sessions, attendees will have the opportunity to participate in question and answer sessions.
Practicing community and academic urologists, PhD researchers, PhD candidates, andrology lab personnel, physician extenders in fertility and urology practices, DVm practitioners and candidates with reproductive focus
ASA 42nd Annual Conference
There have been many recent advances in both the basic science and clinical understanding of male reproductive health. Urologists and basic scientist should be up-to-date on the latest advances, research efforts, and treatment recommendations regarding conditions such as azoospermia, intersex conditions, and the specific concerns of transgendered individuals. Reproductive urologists treat conditions such as varicocele, obstructive and non-obstructive azoospermia, and gender disorder as well as buried penis, and complications of transgender surgery. These practitioners need to be updated on the advances in diagnostic modalities and treatment options for these conditions. Many collaborating Ph.D researchers working in reproductive biology and cell biology do not have an awareness of the clinical management of these conditions, their relatively high prevalence, and the need for an increased understanding of underlying biology of these conditions. Researchers will benefit from awareness of the epidemiology of these conditions, both in terms of their commonality and their predisposition to other urologic and general disease. Furthermore, an understanding of the epidemiologic impact of the treatment for these conditions (in terms of risk to offspring) is vital.
An awareness of future directions for research is useful to the audience as well; updated reviews of spermatogenesis and sperm-cell interactions will help identify future targets for contraceptive treatments and novel treatments in fertility medicine. Finally, new frontiers in clinical medicine including cell culture techniques for spermatogonial stem cells and tissue engineering of urological organs will be explored.
A review of these topics will prove hugely useful to urologists and other MD’s, PhD researchers, DVm’s and trainees as well as physician extenders in andrology and laboratory professionals working in fertility medicine.
At the conclusion of this activity, participants should be able to:
- Review the latest guidelines on the management of male infertility.
- Discuss the epidemiologic importance of male infertility.
- Discuss the epidemiologic impact of treatments for male infertility such as intracytoplasmic sperm injection (ICSI).
- Review the current understanding of spermatogonial stem cell biology.
- Apply lessons regarding appropriateness of transgender surgery to urologic practice.
- Discuss the current understanding of appropriate development of external genitalia in the context of intersex conditions.
- Review the new opportunities for tissue engineering in the management of urological disease.
- Discuss the current understanding of sperm-cell interactions (in the male epididymis, the female reproductive tract, etc.) with the goal of identifying opportunities for modification of sperm function.
- Review the advances in understanding of human and animal spermatogenesis.
2017 ASA SPECIAL SYMPOSIUM
Sexual Function and Fertility in the Spinal Cord Injured Male
Education and training are lacking for clients and practitioners in the management of infertility in men with SCI. Most infertility specialists do not evaluate the male partner of an infertile couple and often do not even refer the men for fertility evaluations. Most urologists have not had much training or exposure in the techniques of sperm retrieval via assisted ejaculation.
At the conclusion of the ASA Special Symposium, attendees should be able to:
- Explain causes of infertility in men with spinal cord injury.
- Distinguish the unique characteristics of infertility in men with spinal cord injury.
- Explain methods of semen retrieval in men with spinal cord injury.
- Assess the fertility status of a man with spinal cord injury and formulate a plan of management appropriate for his sperm quality.